TipRanks
Advertisement
Advertisement
Cytek Biosciences reports Q2 EPS (9c), consensus (2c)
PremiumThe FlyCytek Biosciences reports Q2 EPS (9c), consensus (2c)
2M ago
Cytek Biosciences sees FY26 revenue $207M-$212M, consensus $208.83M
Premium
The Fly
Cytek Biosciences sees FY26 revenue $207M-$212M, consensus $208.83M
2M ago
Cytek Biosciences Announces Chief Legal Officer Transition
Premium
Company Announcements
Cytek Biosciences Announces Chief Legal Officer Transition
3M ago
Cytek Biosciences price target lowered to $5.50 from $6 at Morgan Stanley
PremiumThe FlyCytek Biosciences price target lowered to $5.50 from $6 at Morgan Stanley
5M ago
Cytek Biosciences Faces Rising Risk From U.S.–China Trade Tensions and Tariff Pressures
Premium
Company Announcements
Cytek Biosciences Faces Rising Risk From U.S.–China Trade Tensions and Tariff Pressures
5M ago
Cytek Biosciences Balances Growth Momentum With Cost Pressures
Premium
Company Announcements
Cytek Biosciences Balances Growth Momentum With Cost Pressures
5M ago
Cytek Biosciences assumed with an Equal Weight at Morgan Stanley
PremiumThe FlyCytek Biosciences assumed with an Equal Weight at Morgan Stanley
10M ago
Cytek Biosciences price target lowered to $7.50 from $8 at Piper Sandler
Premium
The Fly
Cytek Biosciences price target lowered to $7.50 from $8 at Piper Sandler
11M ago
Cytek Biosciences Earnings Call: Mixed Sentiment and Growth
Premium
Company Announcements
Cytek Biosciences Earnings Call: Mixed Sentiment and Growth
11M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―